MDM2 INHIBITOR AMG-232
MDM2 INHIBITOR AMG-232 Uses, Dosage, Side Effects, Food Interaction and all others data.
MDM2 INHIBITOR AMG-232 is under investigation in clinical trial NCT03041688 (MDM2 Inhibitor MDM2 INHIBITOR AMG-232 and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid Leukemia).
| Trade Name | MDM2 INHIBITOR AMG-232 |
| Generic | AMG-232 |
| AMG-232 Other Names | MDM2 INHIBITOR AMG-232 |
| Type | |
| Formula | C28H35Cl2NO5S |
| Weight | Average: 568.55 Monoisotopic: 567.1612998 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here MDM2 INHIBITOR AMG-232
